Provided by Tiger Trade Technology Pte. Ltd.

Monkeypox Concept

2,060.26
+7.080.34%
Number of Gainers:5
Number of Losers:4
Number of Flat:2
PE:- -
High:2,071.36
Open:2,037.05
Low:2,021.05
Close:2,053.18
Volume:30.38M
Turnover:1.54B
Market Cap:227.97B
Float Cap:227.26B

Loading ...

Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 28

Moderna Inc. Stock Slips 4.6%, Underperforms Peers

Dow Jones
·
Aug 28

Shield Therapeutics to Assume Full Commercial Control of ACCRUFeR in US

Reuters
·
Aug 27

Virax Biolabs Adjourns Shareholder Meeting After Quorum Fails to Show

Reuters
·
Aug 27

Gilead Sciences Updates Financial Calendar with Investor Conference Presentations

Reuters
·
Aug 27

3 Defensive Dividend Stocks for Investors Seeking Shelter From Market Volatility

Simply Wall St.
·
Aug 26

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Moderna Inc. Stock Rallies 14.4%, Outperforms Peers

Dow Jones
·
Aug 26

Quest Diagnostics Teams with Humanity to Offer Biological Age Analysis on Questhealth.com

Reuters
·
Aug 25

Quest Diagnostics CEO Jim Davis to Speak at Baird Global Healthcare Conference

Reuters
·
Aug 25

August 2026's Highlighted Stocks That May Be Trading Below Estimated Value

Simply Wall St.
·
Aug 25

Quest Diagnostics CFO Sam Samad to Speak at Morgan Stanley Global Healthcare Conference

Reuters
·
Aug 24

Quest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio

MT Newswires Live
·
Aug 24

Tonix Pharma Director Richard H. Bagger Acquires Common Shares Worth $12,600

Reuters
·
Aug 24

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 24

Quest Diagnostics - to Launch New Ad-Detect Multi-Biomarker Lab Test Nationwide at Month-End

THOMSON REUTERS
·
Aug 24

Quest Diagnostics - to Incorporate Roche Ptau217 Test in Ad-Detect Panels in 2027

THOMSON REUTERS
·
Aug 24

EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC

Reuters
·
Aug 24

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status

THOMSON REUTERS
·
Aug 24